Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorRenJi Hospital

About this trial

The study aims to compare the modified approach through ipsilateral deep calf venous access or contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous access for iliofemoral deep venous thrombosis (DVT) with distal popliteal vein thrombosis, and determine whether it can achieve similar therapeutic effects as iliofemoral DVT without distal popliteal vein thrombosis.

Eligibility criteria

Qualifiers

Age between 18-85 years old;

Acute DVT occurred no more than 14 days since the onset of disease;

DVT treated by percutaneous mechanical thrombectomy

Informed consent signed by patients.

Disqualifiers

Patients who are known to be allergic to heparin, low molecular weight heparin, or contrast agent;

Women during pregnancy and lactation;

Patients with other diseases that may cause difficulty in the study or significantly shorten the life expectancy of patients (<6 months);

Patients who are unable or unwilling to participate in the study.

Trial design

Treatments tested in this trial

  • Percutaneous mechanical thrombectomy (PMT) by the modified approach
  • Percutaneous mechanical thrombectomy (PMT) by the traditional approach
  • Traditional approach

Treatment groups

210 Participants
are divided into 3 treatment groups

Sponsors and collaborators

RenJi Hospital

Lead sponsor

First People's Hospital of Hangzhou

Collaborator

Chengdu University of Traditional Chinese Medicine

Collaborator